Jonathan M Peacock Insider Trading $KITE Kite Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jonathan M Peacock.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jonathan M Peacock. Jonathan M Peacock is CFO in AMGEN INC ($AMGN) and EVP & CFO in AMGEN INC ($AMGN) and Director in Kite Pharma, Inc. ($KITE) and in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Bellerophon Therapeutics, Inc. ($BLPH) and President and CEO in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Avantor, Inc. ($AVTR).
Jonathan M Peacock in Kite Pharma, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jonathan M Peacock: Director
Holdings: 69,739 shares
Current Value: $3,718,483
Latest Transaction: Oct 05 2017
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jonathan M Peacock in Kite Pharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMGN, AVTR, BLPH, KITE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | D | 91.21 | 8,810 | 803,560 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | D | 50.87 | 7,000 | 356,090 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | D | 59.23 | 10,000 | 592,300 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | D | 1.35 | 50,000 | 67,500 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Sell | D | 0.00 | 1,807 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Sell | U | 180.00 | 67,932 | 12,227,760 | 1,807 | 69.7 K to 1.8 K (-97.41 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Gift | G | 0.00 | 635 | 0 | 69,739 | 70.4 K to 69.7 K (-0.90 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Grant | A | 0.00 | 2,410 | 0 | 70,374 | 68 K to 70.4 K (+3.55 %) |
| Jun 03 2016 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | A | 50.87 | 7,000 | 356,090 | 7,000 | |
| Jun 03 2016 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Grant | A | 0.00 | 1,950 | 0 | 67,964 | 66 K to 68 K (+2.95 %) |
| Jun 17 2015 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | A | 59.23 | 10,000 | 592,300 | 10,000 |
Page: 1